Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Finel

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
The Polymorphic Variant P24T of UDP-Glucuronosyltransferase 1A4 and Its Unusual ConsequencesJohanna Troberg, Moshe Finel
British Journal of Clinical Pharmacology|February 10, 2019
Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?Moshe Finel, Erkka Järvinen
Current Drug Metabolism|January 29, 2008
The UDP-glucuronosyltransferases as oligomeric enzymesMoshe Finel, Mika Kurkela
Molecular Pharmacology|March 11, 2010
A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzymeLiisa Laakkonen, Moshe Finel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 22, 2010
How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?Katriina Itäaho, Liisa Laakkonen, Moshe Finel
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 26, 2011
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferasesSanna Kaivosaari, Moshe Finel, Mikko Koskinen
The Journal of Steroid Biochemistry and Molecular Biology|November 10, 2019
Human efflux transport of testosterone, epitestosterone and other androgen glucuronidesErkka Järvinen, Heidi Kidron, Moshe Finel
The Journal of Pharmacy and Pharmacology|July 23, 2008
High-throughput screening technologies for drug glucuronidation profilingOlga Trubetskoy, Moshe Finel, Vladimir Trubetskoy
Biochemical Pharmacology|August 5, 2008
The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartanAnna Alonen, Moshe Finel, Risto Kostiainen
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2012
UDP-glucuronic acid binds first and the aglycone substrate binds second to form a ternary complex in UGT1A9-catalyzed reactions, in both the presence and absence of bovine serum albuminNenad Manevski, Jari Yli-Kauhaluoma, Moshe Finel
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
The Polymorphic Variant P24T of UDP-Glucuronosyltransferase 1A4 and Its Unusual ConsequencesJohanna Troberg, Moshe Finel
British Journal of Clinical Pharmacology|February 10, 2019
Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?Moshe Finel, Erkka Järvinen
Current Drug Metabolism|January 29, 2008
The UDP-glucuronosyltransferases as oligomeric enzymesMoshe Finel, Mika Kurkela
Molecular Pharmacology|March 11, 2010
A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzymeLiisa Laakkonen, Moshe Finel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 22, 2010
How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?Katriina Itäaho, Liisa Laakkonen, Moshe Finel
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 26, 2011
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferasesSanna Kaivosaari, Moshe Finel, Mikko Koskinen
The Journal of Steroid Biochemistry and Molecular Biology|November 10, 2019
Human efflux transport of testosterone, epitestosterone and other androgen glucuronidesErkka Järvinen, Heidi Kidron, Moshe Finel
The Journal of Pharmacy and Pharmacology|July 23, 2008
High-throughput screening technologies for drug glucuronidation profilingOlga Trubetskoy, Moshe Finel, Vladimir Trubetskoy
Biochemical Pharmacology|August 5, 2008
The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartanAnna Alonen, Moshe Finel, Risto Kostiainen
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 23, 2012
UDP-glucuronic acid binds first and the aglycone substrate binds second to form a ternary complex in UGT1A9-catalyzed reactions, in both the presence and absence of bovine serum albuminNenad Manevski, Jari Yli-Kauhaluoma, Moshe Finel
Pageof 13